1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow Somatic Mutation: new trials by email Literature Review of Somatic Mutation trials Research Report on Somatic Mutation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies Fludarabine, Busulfan, Melphalan - Hematologic Malignancy, Acute Leukemia | Phase 2 | Recruiting | Masonic Cancer Center, University of Minnesota | 70 | 2023-05-11 | 2026-04-06 |
Anemia, Refractory, with Excess of Blasts (1) · Chromosome 7, monosomy (1) · Chromosome Aberrations (1) · Hematologic Neoplasms (1) · Influenza, Human (1) · Leukemia, Myeloid, Acute (1) · Leukemia, Myelomonocytic, Juvenile (1) · Neoplasm, Residual (1) · Neurofibromatosis 1 (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1) · beta-Thalassemia (1)
Anemia (1) · Anemia, Hemolytic (1) · Anemia, Hemolytic, Congenital (1) · Anemia, Refractory (1) · Bone Marrow Diseases (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Hemoglobinopathies (1) · Heredodegenerative Disorders, Nervous System (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Infections (1) · Leukemia (1)
Busulfan (1) · Cyclophosphamide (1) · Levetiracetam (1) · Melphalan (1) · Rituximab (1) · fludarabine (1) · thymoglobulin (1)
Masonic Cancer Center, University of Minnesota (1)
United States (1)